M&A Deal Summary |
|
|---|---|
| Date | 2021-02-01 |
| Target | Expereo International |
| Sector | Communications |
| Buyer(s) | Vitruvian Partners |
| Sellers(s) | Seven2 |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2006 |
| PE ASSETS | 8.5B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Vitruvian Partners is an independent private equity firm that specializes in middle-market buyouts, growth buyouts and growth capital investments in the UK and elsewhere in Northern Europe. Vitruvian looks for companies that are 'operating in dynamic situations, where there is an opportunity to build strategic value'. The Group's target investment size is £25 to £150 million in transactions valued up to £500 million. Sectors of interest include business services, consumer services, financial services, life science, healthcare services, media, technology, communications, and internet software. Vitruvian Partners was formed in 2006 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 42 of 59 |
| Sector (Communications) | 1 of 1 |
| Type (Secondary Buyout) | 10 of 14 |
| Country (Netherlands) | 2 of 2 |
| Year (2021) | 2 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-12 |
Carne Group
Dublin, Ireland Carne Group is a digitally driven industry platform serving the global asset management industry and the largest third-party fund management company in the world. Carne is trusted by asset managers, insurance companies, pension funds and wealth managers to manage their governance, compliance, regulatory and substance requirements. Carne Group was formed in 2004 and is based in Dublin, Ireland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-05 |
Oxford Biomedica
Oxford, United Kingdom Oxford Biomedica is a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno associated virus, adenoviral vectors, and other viral vector types. Oxford Biomedica was founded in 1995 and is based in Oxford, United Kingdom. |
Buy | - |
Seven2 is a private equity firm focused on investments in listed and unlisted small and midcap companies located in Continental Europe. The Firm targets growing businesses in the tech and telecom, consumer, and healthcare services sectors valued between €10 million and €1 billion. Seven2 generally has a five year investment horizon and considers minority and majority positions. Seven2 was established in 1972 and is headquartered in Paris, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Communications) | 1 of 2 |
| Type (Secondary Buyout) | 1 of 2 |
| Country (Netherlands) | 1 of 1 |
| Year (2021) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-08 |
Mentaal Beter
Hilversum, Netherlands Mentaal Beter is a mental health care services provider active in the mild to moderate severity mental care and learnings disorder market in the Netherlands. After a merger with Parigger & de Heer in 2009, Mentaal Beter added its own branches and professionals to the payroll. In 2010, the mental health care organisation became part of the healthcare company Interhealth. Mentaal Beter was founded in 2004 and is based in Hilversum, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-16 |
BTP Consultants
Saint-Quentin-en-Yvelines, France BTP Consultants provides TIC (Testing, Inspection & Certification) in the building industry. BTP Consultants Group is made up of three companies: BTP Consultants, Citae and MBAcity. BTP Consultants was founded in 1996 and is based in Saint-Quentin-en-Yvelines, France. |
Buy | - |
